← Back to Search

Weight Loss + Exercise for Aging-related Inflammation (ALIVE Trial)

N/A
Waitlist Available
Led By Jacob B Blumenthal, MD
Research Sponsored by University of Maryland, College Park
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All women over the age of 50 must be postmenopausal for at least 1 year, have serum FSH >30 mIU/ml, and agree to remain off hormone replacement therapy for the duration of the study
Be older than 18 years old
Must not have
HIV (+) or other disease prone to malnutrition
Sickle cell anemia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is for people who are overweight and want to improve their health. You may lose a moderate amount of weight and increase your activity, which can improve health by reducing inflammation.

Who is the study for?
This study is for veterans who are overweight with a waist size of 80-120cm for men or 70-110cm for women, have a stable medical regimen, and BMI between 20-40. Women over 50 must be postmenopausal. Participants should not smoke, have certain chronic diseases, uncontrolled hypertension, recent significant weight changes, or use medications affecting metabolism.
What is being tested?
The trial aims to see if losing some weight and doing more aerobic exercise can reduce inflammation in the body. It's looking at how age and body fat affect the production of inflammatory chemicals and whether these lifestyle changes can improve health outcomes related to being overweight.
What are the potential side effects?
While specific side effects aren't listed for this lifestyle intervention trial involving weight loss and exercise, participants may experience muscle soreness, fatigue or injury from increased physical activity. Any other adverse effects will likely be monitored by the research team.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman over 50, postmenopausal for 1+ year, and not on hormone therapy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am HIV positive or have a condition that could lead to malnutrition.
Select...
I have sickle cell anemia.
Select...
I need oxygen therapy for my lung condition.
Select...
I cannot exercise due to heart or brain blood vessel issues.
Select...
I need more than 3 medications or beta blockers to manage my high blood pressure.
Select...
My weight has changed by more than 5kg in the last 3 months.
Select...
I have a long-term liver, kidney, or blood disease.
Select...
I am currently receiving radiation or chemotherapy for my cancer.
Select...
I have long-term depression that I haven't treated.
Select...
I have had a stroke that affects one side of my body.
Select...
I have diabetes and am on medication, or my fasting blood sugar is over 126 mg/dl.
Select...
I have high cholesterol or triglycerides, or I'm taking Lipitor or Crestor.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Lifestyle ModificationExperimental Treatment1 Intervention
Combined hypocaloric diet and aerobic exercise training

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkLead Sponsor
159 Previous Clinical Trials
46,363 Total Patients Enrolled
5 Trials studying Aging
506 Patients Enrolled for Aging
University of Maryland, BaltimoreLead Sponsor
716 Previous Clinical Trials
381,014 Total Patients Enrolled
6 Trials studying Aging
230 Patients Enrolled for Aging
US Department of Veterans AffairsFED
875 Previous Clinical Trials
498,321 Total Patients Enrolled
11 Trials studying Aging
1,976 Patients Enrolled for Aging
Jacob B Blumenthal, MDPrincipal InvestigatorBaltimore VA Medical Center, University of Maryland

Media Library

Weight loss and aerobic exercise training Clinical Trial Eligibility Overview. Trial Name: NCT00667030 — N/A
Aging Research Study Groups: Lifestyle Modification
Aging Clinical Trial 2023: Weight loss and aerobic exercise training Highlights & Side Effects. Trial Name: NCT00667030 — N/A
Weight loss and aerobic exercise training 2023 Treatment Timeline for Medical Study. Trial Name: NCT00667030 — N/A
Aging Patient Testimony for trial: Trial Name: NCT00667030 — N/A
~4 spots leftby Dec 2025